DISCO Pharmaceuticals GmbH

Join DISCO's Emanuela Milani-Tschudy and Heidi Funke in Dresden, Germany for the 23rd HUPO World🌍Congress from 20-24 October.   💬 Connect with Emanuela and Heidi onsite to explore how DISCO Pharmaceuticals GmbH is transforming #cancer care by expanding the molecular target🎯space with our cutting-edge #surfaceome mapping technology🦠.   The Human Proteome Organization (#HUPO) World Congress brings together industry experts in #proteomics to discuss the latest innovations, from early-stage discovery through to clinical applications 🔬.    #HUPO2024 EuPA - European Proteomics Association #DGPF #Optoproteomics #DrugDiscovery 

Our Head of Technology & DISCO Zürich, Emanuela Milani-Tschudy Tschudy-Milani, will be attending the Festival of Biologics in Basel, Switzerland🗻from 15th to 17th October.    Reach out if you would like to connect with Emanuela 🌐🗨️onsite to learn more about how we're transforming cancer care with our disruptive #surfaceome mapping technology.     The #FestivalofBiologics brings together 4,000 industry professionals together to bridge the gap between academia and industry, covering the start to finish of biologics from discovery, through development, to manufacturing, clinical trials and commercialisation.   See you in Basel! 🎉🔬   📲 Stay connected and keep up to date with @DISCO Pharmaceuticals by following on LinkedIn and on X DISCO Pharmaceuticals GmbH   #FestivalofBiologics2024 #Proteomics #Optoproteomics #DrugDiscovery #Biotech

DISCO Pharmaceuticals GmbH has been featured in Drug Discovery World's latest article on the future of antibody drug conjugates (#ADCs).   The article highlights the challenges in #ADC development including off-target toxicity and drug resistance. At DISCO, we are committed to mitigating these risks by prioritising careful target🎯selection and bispecific innovation, using our disruptive #surfaceome mapping technology, always keeping those affected by #cancer at the heart❤️of our mission.   Read the full article to learn more about the ADC revolution here👉https://bit.ly/3zAaFwf   #AntibodyDrugConjugates #CancerResearch #SmallCellLungCancer #ColorectalCancer #DrugDiscovery #proteomics #optoproteomics

DISCO Pharmaceuticals GmbH has been featured in Drug Discovery World's latest article on the future of antibody drug conjugates (#ADCs).   The article highlights the challenges in #ADC development including off-target toxicity and drug resistance. At DISCO, we are committed to mitigating these risks by prioritising careful target🎯selection and bispecific innovation, using our disruptive #surfaceome mapping technology, always keeping those affected by #cancer at the heart❤️of our mission.   Read the full article to learn more about the ADC revolution here👉https://bit.ly/3zAaFwf   #AntibodyDrugConjugates #CancerResearch #SmallCellLungCancer #ColorectalCancer #DrugDiscovery #proteomics #optoproteomics

On #WorldLungDay, DISCO Pharmaceuticals GmbH is proud to stand with the global community in raising awareness about lung health and the impact of lung diseases such as #LungCancer.   At DISCO, we are at the forefront of innovation. With our breakthrough cell #surfaceome discovery technology, we have completed the first-ever mapping of #SmallCellLungCancer (SCLC). Leveraging this knowledge, we have launched the development of #SCLC target-specific therapeutics, and we are committed to improving patient care by providing more effective, targeted treatment options.    Learn more about how we are transforming cancer care by expanding the molecular target space using the link in the first comment below.   #WLD #WLD2024 #LungHealth #HealthForAll #HealthyLungsForLife #drugdiscovery #proteomics #optoproteomics  

📢 DISCO Pharmaceuticals GmbH has been shortlisted for Seed Raise of the Year 🌱 for the @European Lifestars Awards - Celebrating Life Science Leaders! The winners will be announced at the awards ceremony🎉on the 18 November at the Honourable Artillery Company in London. We are very pleased to be recognised alongside other exceptional nominees and are incredibly proud of the #DISCO team for their continued dedication in our mission to change the future of cancer-targeted therapies of all modalities with our cutting edge #surfaceome mapping technology. #LifestarsAwards #drugdiscovery #biotech @LSX - partnering for Life Science eXecutives

Looking ahead, there’s lots of optimism in the sector as noted in Melanie Senior recent article ‘Biotech financing: darkest before the dawn’ published in Nature Portfolio's Biotechnology. Alongside other notable events, DISCO Pharmaceuticals GmbH’s €20m seed financing suggests the sector is headed in the right direction. Read the full article here 👉 https://lnkd.in/eWXV2y3q

Sometimes you need to retreat from the spotlight and relax a little bit.    And that’s exactly what we did.   For this year’s offsite #CompanyRetreat, DISCO team members from Cologne and Zurich sashayed their way to Karlsruhe, a sun-soaked☀ city full of rich culture and tradition situated between the Rhine and the Black Forest🌲in southwest Germany.   We kicked off the retreat with a little bit of reflection to discuss what we have achieved so far and what will be our focus for the next year.   However, we also had plenty of time to relax and get to know each other beyond the science🔬. We connected over delicious tapas, football ⚽ and a treasure hunt💰through the city centre tested our #teambuilding skills and fortified our competitive nature and drive.   We are rested and recharged, ready to continue our mission in transforming cancer care.   #mentalhealth #wellness #collaboration

Today on World Lung Cancer Day, we want to raise awareness of the most aggressive form of lung cancer: Small Cell Lung Cancer (#SCLC). At DISCO Pharmaceuticals GmbH, using our target discovery platform, we have completed the first-ever mapping of the SCLC #surfaceome. This has revealed countless novel proteins and protein communities on the surface of SCLC cells providing target🎯candidates for mono- and bi-specific #antibodytherapeutics Using this knowledge, we have launched the development of SCLC target-specific therapeutics to improve #patient care by providing more effective, targeted treatment options. To learn more about our cell surfaceome discovery technology, visit the link in the comments below. #WorldLungCancerDay #WLCD2024 #LungCancerAwareness #SmallCellLungCancer

Our CEO, Roman Thomas, recently spoke🎙to Janelle Hart, Managing Editor at Citeline, following his recognition as one of In Vivo's Rising Leaders earlier this year. The article published today, Roman outlines the background behind DISCO Pharmaceuticals GmbH Pharmaceuticals, our target🎯discovery platform technology and its potential to redefine cancer drug discovery.   You can read the article📰using the link in the comments below.    #InVivosRisingLeaders2024